AI tools to predict blood vessel disease risk and progression
Part of Heart & circulation clinical trials.
This trial uses artificial intelligence to develop better ways to predict the risk and progression of two blood vessel conditions: abdominal aortic aneurysm (a bulging in the main belly artery) and peripheral artery disease (narrowed arteries in the legs). If you have one of these conditions, researchers want to learn from your data to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 90 years old.
- You have an abdominal aortic aneurysm larger than 3 cm (including aneurysms in the belly or pelvic arteries, or after surgery or a rupture).
- You have peripheral artery disease, at any stage (even mild or severe).
- You do not have an aneurysm in the chest or upper abdominal aorta (types 1-3 thoracoabdominal).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to develop trustworthy artificial intelligence (AI) tools to predict the risk and progression of vascular diseases like abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). Participants will use a mobile health app to help researchers create better prediction models.
This trial tests an artificial intelligence tool to help find peripheral artery disease (PAD) early, before it causes problems. It may catch the condition in people who don't yet know they have it.
This trial uses artificial intelligence (a computer program) to predict complications after a minimally invasive surgery to fix a bulging blood vessel in the belly (abdominal aortic aneurysm). It may help doctors better understand your recovery.
This trial uses artificial intelligence to better analyze CT scans of the aorta, the large artery that carries blood from your heart. If your CT scan shows the aorta is partly cut off or missing in the images, the AI will help measure the parts that are fully visible.
This study looks at blood and/or scan markers to better understand abdominal aortic aneurysms (AAA). It may help doctors predict risks and guide follow-up or treatment choices.
This trial uses artificial intelligence to analyze CT scans and microscope images of the main leg artery. It aims to improve understanding of artery structure. Participation is only for patients who are already scheduled for a leg amputation as part of their medical care.
Hear when a new Aneurysm Abdominal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.